Stifel Financial
SANA icon

Stifel Financial’s Sana Biotechnology SANA Stock Holding History

Stifel Financial’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,314
Closed -$78.6K – 3735
2025
Q4 		$78.6K Hold
19,314
– – ﹤0.01% 3501
2025
Q3 		$68.6K Buy
+19,314
New +$69.8K ﹤0.01% 3476
2025
Q1 		– Sell
-10,397
Closed -$16.9K – 3525
2024
Q4 		$16.9K Buy
10,397
+132
+1% +$394 ﹤0.01% 3356
2024
Q3 		$42.7K Buy
+10,265
New +$53.9K ﹤0.01% 3307
2021
Q2 		– Sell
-23,595
Closed -$790K – 3380
2021
Q1 		$790K Buy
+23,595
New +$768K ﹤0.01% 2154

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Stifel Financial's SANA Position: Q1 2026 in Review

Stifel Financial sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 19,314 shares — an estimated $78.6K sold.

Stifel Financial first reported a position in SANA in Q1 2021 and held it in 5 quarters. The position peaked at $790K in Q1 2021. 203 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Stifel Financial reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Stifel Financial sold 19,314 Sana Biotechnology shares in Q1 2026, an estimated $78.6K.
  • Stifel Financial first reported a position in Sana Biotechnology in Q1 2021 and held it in 5 quarters.
  • Stifel Financial's Sana Biotechnology position peaked at $790K in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.